GANIRELIX ACETATE S Code: S0132

Drug & Product Overview

HCPCS Descriptor Injection, ganirelix acetate, 250 mcg

HCPCS Added Date April 1, 2002

Manufacturer Multiple Manufacturers

Route of Administration Subcutaneous

Generic Status Multi-Source; Generic

Dosage Type Single-Dose

Dosage Form Injection | Injection, Solution

About GANIRELIX ACETATE

Ganirelix Acetate is a medication aligned to the HCPCS S Code: S0132 for billing, pricing, and reimbursement purposes in the United States. This Fertility medication is administered via the subcutaneous route and manufactured by multiple companies.

Manufacturers, reach out to us to add more information.

NDC Code Information

3 NDC packages are crosswalked to S0132. Package detail is available to logged-in subscribers.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
•••••-••••-•• Log in to view	GANIRELIX ACETATE
	GANIRELIX ACETATE
	GANIRELIX ACETATE

Login to view 3 NDC packages View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

GANIRELIX ACETATE Pricing & Reimbursement

S0132 Private Payer Reimbursement

$188.38 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

GANIRELIX ACETATE CPT Administration Codes

CPT Code	Description
96372	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); intramuscular

Not on the CMS JW / JZ list

CMS does not include Ganirelix Acetate (S0132) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing S0132. Wastage billing guide →

GANIRELIX ACETATE Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation inhibition of premature LH surges in women undergoing controlled ovarian hyperstimulation

Drug Class

Decreased GnRH Secretion [PE]Gonadotropin Releasing Hormone Receptor Antagonist [EPC]Gonadotropin Releasing Hormone Receptor Antagonists [MoA]

Frequently Asked Questions

Is there an available Ganirelix Acetate billing and coding guide?

We have not yet identified a manufacturer source of Ganirelix Acetate billing and coding information.

Are there any available Ganirelix Acetate patient assistance programs?

Our team did not identify a source for Ganirelix Acetate patient assistance information. Please reach out to our team if you feel that this is a mistake.

Where can I find Ganirelix Acetate prescribing information?

Our team is still working to identify a prescribing information source for GANIRELIX ACETATE

Where can I find Ganirelix Acetate side effect information?

Our team has not yet identified a source of side effects information for GANIRELIX ACETATE. Please check back in a few weeks.

Does billing GANIRELIX ACETATE require JZ/JW wastage modifiers?

CMS does not include GANIRELIX ACETATE (S0132) on its list of HCPCS pertaining to single-dose containers. Per CMS guidelines, the JZ/JW wastage modifiers may not apply when billing S0132. For more information, visit the link below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.